13F filer · CIK 2043476
B Group, Inc.
DALLAS, TX · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$213.0M
+$78.1M vs prior
Positions
19
New / sold out
2 / 3
Added / reduced
5 / 1
Turnover
2.2%
buys $59.3M · sells $3.7M
Top-10 weight
79.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | INVESCO QQQ TRPUT | +50,000 | – | +$36.8M |
| New | FAETH THERAPEUTICS INC | +610,169 | – | +$15.3M |
| Added | NRX PHARMACEUTICALS INC | +1,091,767 | +36.4% | +$4.5M |
| Added | AURA BIOSCIENCES INC | +166,667 | +27.9% | +$1.2M |
| Added | STRUCTURE THERAPEUTICS INC | +12,500 | +9.8% | +$670.9K |
| Added | FOGHORN THERAPEUTICS INC | +98,000 | +96.1% | +$478.2K |
| Added | ADMA BIOLOGICS INC | +55,000 | +1.7% | +$460.4K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SPYRE THERAPEUTICS INC | -30,000 | -30.0% | $-2.7M |
| Sold out | APOGEE THERAPEUTICS INC | -7,500 | -100.0% | $-631.3K |
| Sold out | SOLENO THERAPEUTICS INC | -7,500 | -100.0% | $-251.1K |
| Sold out | REPLIMUNE GROUP INC | -26,000 | -100.0% | $-198.9K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | INVESCO QQQ TRPUTPUT | 50,000 | $36.8M | 17.29% |
| 2 | ADMA BIOLOGICS INCCOM | 3,262,542 | $27.3M | 12.82% |
| 3 | PALISADE BIO INCCOM | 11,414,285 | $23.9M | 11.20% |
| 4 | NRX PHARMACEUTICALS INCCOM NEW | 4,091,767 | $16.7M | 7.86% |
| 5 | FAETH THERAPEUTICS INCCOM NEW | 610,169 | $15.3M | 7.16% |
| 6 | TAYSHA GENE THERAPIES INCCOM SHS | 1,800,556 | $12.3M | 5.76% |
| 7 | PRAXIS PRECISION MEDICINES ICOM NEW | 33,237 | $11.1M | 5.22% |
| 8 | CELLECTIS S ASPON ADS | 3,281,501 | $9.8M | 4.62% |
| 9 | ZAI LAB LTDADR | 450,646 | $8.6M | 4.02% |
| 10 | STRUCTURE THERAPEUTICS INCSPONSORED ADS | 140,000 | $7.5M | 3.53% |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.